{
    "Title": "In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination",
    "URL": "https://doi.org/10.1371/journal.pntd.0005584",
    "Published": "May 8, 2017",
    "Subject_Areas": [
        "Viral vaccines",
        "Antibodies",
        "Dengue virus",
        "Vaccine development",
        "Dengue fever",
        "Vaccination and immunization",
        "Viremia",
        "Antibody response"
    ],
    "Authors": {
        "Stephen S. Whitehead": [
            "Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Anna P. Durbin": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Kristen K. Pierce": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Dan Elwood": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Benjamin D. McElvany": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Ellen A. Fraser": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Marya P. Carmolli": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Cecilia M. Tibery": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Noreen A. Hynes": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Matthew Jo": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Janece M. Lovchik": [
            "Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore, Maryland; United States of America"
        ],
        "Catherine J. Larsson": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Elena A. Doty": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Dorothy M. Dickson": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Catherine J. Luke": [
            "Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Kanta Subbarao": [
            "Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Sean A. Diehl": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Beth D. Kirkpatrick": [
            "Vaccine Testing Center, Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, United States of America"
        ]
    }
}